Citi Starts Epizyme (EPZM) at Buy
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/12/2026
- S&P 500 ends higher as CoreWeave results fuel AI optimism
- Oil prices edge up as investors weigh US-Iran talks deadlock against lower demand
- CoreWeave soars after fifth straight quarter of record revenue, raised guide
- Four key things investors will watch in Nvidia's earnings next week
- Silver could surge to $90 as investment demand takes over, Citi says
- Lumentum Holdings (LITE) Tops Q4 EPS by 28c, Beats on Revenue; Offers Q1 Guidance
- Crude Inventory Rose 17.2 Million Barrels Last Week - EIA
- Aurora Cannabis rejects Curaleaf's unsolicited $4-per-share takeover bid
- AbCellera Biologics (ABCL) PT Raised to $30 at Truist on 'best-in-class potential'
- Comscore plans restructuring with $20M-$25M in cost cuts
- After-Hours Movers: CSCO, COHR, HLIT, CBRS, STUB, ENS
- After-Hours Movers: CRWV, NBIS, SMCI, LITE, CAVA, HRB
- After-Hours Movers: P, RIOT, BW, RKLB, HIMS, UPWK
- After-Hours Movers: TEAM, NET, TWLO, DOCS, FROG, DV, TTD, ABNB, DKNG, SG, RKT
- After-Hours Stock Movers: WDC, SNDK, FIG, APP, HUBS, SOUN, DASH, XYZ, Z, FLNC
Wedbush Starts Epizyme (EPZM) at Outperform
June 26, 2013 4:49 PM EDTWedbush initiated coverage on Epizyme (NASDAQ: EPZM) with an Outperform rating and a price target of $37.00.
"Advances in genetically defining sub-sets of cancer patients have identified members of the family of histone methyltransferase (HMT) proteins as key drivers of malignancy. . .... More
Cowen Starts Epizyme (EPZM) at Outperform
June 25, 2013 10:32 AM EDTCowen initiates coverage on Epizyme (NASDAQ: EPZM) with a Outperform.
For an analyst ratings summary and ratings history on Epizyme click here. For more ratings news on Epizyme click here.
Shares of Epizyme closed at $27.55 yesterday, with a 52 week range of $18.60-$30.86.... More
JMP Securities Starts Epizyme (EPZM) at Market Outperform
June 25, 2013 8:46 AM EDTJMP Securities initiates coverage on Epizyme (NASDAQ: EPZM) with a Market Outperform.
For an analyst ratings summary and ratings history on Epizyme click here. For more ratings news on Epizyme click here.
Shares of Epizyme closed at $27.55 yesterday, with a 52 week range of $18.60-$30.86.... More
Leerink Swann Starts Epizyme (EPZM) at Outperform
June 25, 2013 7:50 AM EDTLeerink Swann initiates coverage on Epizyme (NASDAQ: EPZM) with a Outperform. PT $34.00.
For an analyst ratings summary and ratings history on Epizyme click here. For more ratings news on Epizyme click here.
Shares of Epizyme closed at $27.55 yesterday, with a 52 week range of $18.60-$30.86.... More
